Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation

Journal of the American College of Cardiology

Volumn 59, Issue 2, 2012, Pages 143-149

  Shah, Rashmee U ^a   Freeman, James V ^a   Shilane, David ^a   Wang, Paul J ^a   Go, Alan S ^b,c   Hlatky, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

atrial fibrillation; complication; outcomes; pulmonary vein isolation

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLEEDING; CATHETER ABLATION; CLINICAL COMPETENCE; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERFORATION; PNEUMOTHORAX; PRIORITY JOURNAL; PROGNOSIS; REPEAT PROCEDURE; SEX DIFFERENCE; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CALIFORNIA; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; REOPERATION; TREATMENT OUTCOME;

EID: 84855367713     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.08.068     Document Type: Article

References (22)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
2. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25. (Pubitemid 44420743)
3. Lubitz SA, Fischer A, Fuster V. Catheter ablation for atrial fibrillation. BMJ 2008;336:819-26. (Pubitemid 351548225)
4. Cappato R, Calkins H, Chen S-A, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-5. (Pubitemid 40365469)
5. Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011;57:160-6.
6. Ellis ER, Culler SD, Simon AW, Reynolds MR. Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm 2009;6:1267-73.
7. HCUP State Inpatient Databases (SID). Healthcare Cost and Utilization Project (HCUP). 2005-2009. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.hcup-us.ahrq.gov/sidoverview.jsp. Accessed July 10, 2011.
8. Curtis JP, Schreiner G, Wang Y, et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients. J Am Coll Cardiol 2009;54:903-7.
9. Bertaglia E, Zoppo F, Tondo C, et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. Heart Rhythm 2007;4:1265-71. (Pubitemid 47495727)
10. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Europace 2007;9:335-79.
11. Bueno H, Ross JS, Wang Y, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010;303:2141-7.
12. Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005;293:2634-40. (Pubitemid 40744248)
13. Stabile G, Bertaglia E, Senatore G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multicentre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation study). Eur Heart J 2006;27:216-21. (Pubitemid 43069040)
14. Ahmed B, Piper WD, Malenka D, et al. Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry. Circ Cardiovasc Interv 2009;2:423-9.
15. Piper WD, Malenka DJ, Ryan TJ Jr., et al. Predicting vascular complications in percutaneous coronary interventions. Am Heart J 2003;145:1022-9. (Pubitemid 36688253)
16. Argulian E, Patel AD, Abramson JL, et al. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol 2006;98:48-53. (Pubitemid 43902676)
17. Cheng S, Morrow DA, Sloan S, Antman EM, Sabatine MS. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. Circulation 2009;119:1195-202.
18. Juergens CP, Semsarian C, Keech AC, Beller EM, Harris PJ. Hemorrhagic complications of intravenous heparin use. Am J Cardiol 1997;80:150-4. (Pubitemid 27329212)
19. Feasby TE, Quan H, Ghali WA. Hospital and surgeon determinants of carotid endarterectomy outcomes. Arch Neurol 2002;59:1877-81. (Pubitemid 35424644)
20. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. The relation between hospital procedure volume and complications of cardioverter- defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2010;56:1133-9.
21. Peterson ED, Coombs LP, DeLong ER, Haan CK, Ferguson TB. Procedural volume as a marker of quality for CABG surgery. JAMA 2004;291:195-201. (Pubitemid 38082813)
22. Ross JS, Normand S-LT, Wang Y, et al. Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med 2010;362:1110-8.